+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vectura Group plc - logo

Vectura Pharma was established in 1997, and its headquarters are in Chippenham in the U.K. Vectura Group plc researches, develops, and commercializes novel therapeutic products and drug delivery systems for the treatment of airways-related diseases Vectura entered into its first global commercialisation and development agreement with Novartis for NVA237. The company’s marketed products include Ultibro Breezhaler and Seebri Breezhaler for the treatment of chronic obstructive pulmonary disease (COPD).

From
Anti-Asthmatics and COPD Drugs Global Market Report 2024 - Product Thumbnail Image

Anti-Asthmatics and COPD Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Controlled Release Drug Delivery Global Market Report 2024 - Product Thumbnail Image

Controlled Release Drug Delivery Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
Pharmaceutical API Manufacturing Global Market Report 2024 - Product Thumbnail Image

Pharmaceutical API Manufacturing Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
From
Loading Indicator